Recrudescence of Deficits After Stroke

Abstract

Reemergence of previous stroke-related deficits (or poststroke recrudescence [PSR]) is an underrecognized and inadequately characterized phenomenon. OBJECTIVE To investigate the clinical features, triggers, and risk factors for PSR. DESIGN, SETTING, AND PARTICIPANTS This retrospective study incorporated a crossover cohort study to identify triggers and a case-control study to identify risk factors. The study used the Massachusetts General Hospital Research Patient Data Repository to identify patients for the period January 1, 2000, to November 30, 2015, who had a primary or secondary diagnosis of cerebrovascular disease, who underwent magnetic resonance imaging of the brain at least once, and whose inpatient or outpatient clinician note or discharge summary stated the term recrudescence. In all, 153 patients met the preliminary diagnostic criteria for PSR: transient worsening of residual poststroke focal neurologic deficits or transient recurrence of prior stroke-related focal deficits, admission magnetic resonance imaging showing a chronic stroke but no acute infarct or hemorrhage, no evidence of transient ischemic attack or seizure, no acute lesion on diffusion-weighted imaging, and no clinical or electroencephalographic evidence of seizure around the time of the event. MAIN OUTCOMES AND MEASURES Clinical and imaging features of PSR; triggers (identified by comparing PSR admissions with adjacent admissions without PSR); and risk factors (identified by comparing PSR cases with control cases from the Massachusetts General Hospital Stroke Registry). RESULTS Of the 153 patients, 145 had prior infarct, 8 had hypertensive brain hemorrhage, and 164 admissions for PSR were identified. The patients' mean (SD) age was 67 (16) years, and 92 (60%) were women. Recrudescence occurred a mean (SD) of 3.9 (0.6) years after the stroke, lasted 18.4 (20.4) hours, and was resolved on day 1 for 91 of the 131 episodes with documented resolution time (69%). Deficits were typically abrupt and mild and affected motor-sensory or language function. No patient had isolated gaze paresis, hemianopia, or neglect. During PSR, the National Institutes of Health Stroke Scale (NIHSS) score worsened by a mean (SD) 2.5 (1.9) points, and deficits were limited to a single NIHSS item in 62 episodes (38%). The underlying chronic strokes were variably sized, predominantly affected white matter tracts, and involved the middle cerebral artery territory for 112 patients (73%). Infection, hypotension, hyponatremia, insomnia or stress, and benzodiazepine use were higher during PSR admissions. Compared with the control group (patients who did not experience recrudescence), the PSR group (patients who were hospitalized for recrudescence) had more women, African American individuals, and those who self-identified as being from "other" race. The PSR group also had more diabetes, dyslipidemia, smoking, infarcts from small-vessel disease, and "other definite" causes and worse onset NIHSS scores. Six patients (4%) received intravenous tissue plasminogen activator wi...

Outcomes After Percutaneous Coronary Intervention in Patients With a History of Cerebrovascular Disease

“…Recrudescence of stroke symptoms may be caused by the use of sedating medications frequently used during PCI. 29 This may have led to an overestimation of the incidence of post-PCI stroke in the subgroup of patients with a history of TIA or stroke. However, our definition of post-PCI stroke required symptoms to be present for at least 24 hours, whereas among patients with symptoms due to post-stroke recrudescence, the majority have resolution of symptoms within 24 hours.…”

A Case of COVID-19 With Memory Impairment and Delayed Presentation as Stroke

“…Interestingly, the neuroimaging was suggestive of an old infarct with new-onset symptoms, which may possibly be related to post-stroke recrudescence (PSR). This has been previously very well described in a cohort study that included 153 patients, of whom 112 patients (73%) exhibited re-emergence of previous stroke-related deficits involving white matter tracts and MCA territory [19]. Stress, metabolic derangements, and infections are some of the risk factors for PSR.…”

“…Novel coronavirus disease 2019 (COVID- 19) is associated with significant morbidity and mortality, with more than 19 million cases and 727,000 deaths worldwide as of August 8, 2020 [1]. The disease ranges from asymptomatic infection to severe illness, which varies among different patients for reasons that are currently unclear [2].…”

Longer term stroke risk in intracerebral haemorrhage survivors

“…New neurological symptoms in ICH survivors can represent a recrudescence of previous stroke symptoms, which could be misdiagnosed as a new cerebrovascular event, particularly in the absence of appropriate investigations including MRI brain with diffusion-weighted sequences. 25 Additionally, in order to complete competing risk analyses, only the first cerebrovascular event was considered; this work did not explore repeated events, and in patients who had both ischaemic and haemorrhagic events, only the first event was included. The number of outcome events was relatively low, and as a consequence, we were unable to explore the role of ICH location in further detail (ie, in those with cerebellar or brainstem ICH); additionally, we were unable to comment on the clinical severity of the outcome events, as this information was not available.…”